Fennec Pharmaceuticals In...

NASDAQ: FENC · Real-Time Price · USD
8.39
-0.14 (-1.64%)
At close: Aug 15, 2025, 3:59 PM
8.36
-0.36%
After-hours: Aug 15, 2025, 04:10 PM EDT

Fennec Pharmaceuticals Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-70K -16.05M -23.71M -17.35M
Depreciation & Amortization
800K n/a 132K 14K
Stock-Based Compensation
5.06M 5.35M 4.22M 4.01M
Other Working Capital
16.13M 819.83K 1.61M -138K
Other Non-Cash Items
5.06M 326K 334K 307K
Deferred Income Tax
n/a n/a n/a -14K
Change in Working Capital
16.13M -6.78M 1.1M -932K
Operating Cash Flow
26.98M -17.14M -18.06M -14.22M
Capital Expenditures
n/a 2.75 n/a n/a
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
n/a n/a n/a n/a
Debt Repayment
-13M 5M 19.93M 5M
Common Stock Repurchased
n/a -78K -194K n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-167.55K 1.64M 797K -22K
Financial Cash Flow
-13.62M 6.64M 20.73M 4.98M
Net Cash Flow
13.37M -10.51M 2.67M -9.24M
Free Cash Flow
26.98M -17.14M -18.06M -14.22M